Lung cancer is one of the leading causes of death world-wide with the majority of patients suffering from advanced unresectable or metastatic non-small cell lung cancer. Despite the advances in palliative chemotherapy, the survival rate for patients with this advanced disease treated with chemotherapy remains poor. In this book, the authors present topical research in the study of lung cancer treatments including epidermal growth factor tyrosine kinase inhibitors, in the management of advanced stage non-small cell lung cancer; lung cancer brachytherapy; volumetric modulated arc therapy and future individualised therapy for lung cancer in post-genomic era.
Preface; Epidermal Growth Factor Tyrosine Kinase Inhibitors in the Management of Advanced Stage Non-Small Cell Lung Cancer; Lung Cancer Brachytherapy; Update Chemotherapy Schedule in the Treatment of Lung Cancer; Treatment of Small Cell Lung Cancer; Volumetric Modulated Arc Therapy in the Treatment of Lung Cancer; Future Individualized Therapy for Lung Cancer in Post-Genomic Era; Pulmonary Drug Delivery System:: Inhalable Nanocomposite Particles for the Treatment of Lung Cancer; Lung Cancer Treatment; Index.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.